​Petter W. Bjornstad is a seasoned international executive and serial entrepreneur with over 30 years of experience building and scaling ventures across life sciences, cleantech, and deep tech sectors. He is the founder of InsuLife AS, developing a needle-free transdermal insulin spray, co-founder and chairman of Crinexa Inc., advancing hormone therapies via transdermal delivery and chairman of Greentech Americas, scaling waste-to-value technologies.
A strategic relationship builder, he has conducted business across the full value chain in multiple industries and has been instrumental in creating and growing ventures from incorporation to commercialization and public listing. His experience spans operational design, capital raising, acquisitions, and market development.

Based in the United States and holding dual citizenship in Norway and the U.S., Petter operates at the intersection of Nordic innovation and American commercialization, bridging technology, capital, and regulatory pathways across both regions.